Dr. Usman Tahir, Director of the Center for Cardiovascular Genetics at BIDMC, discusses the current genetic paradigm for hypertrophic cardiomyopathy (HCM). He also reviews new risk markers for sudden cardiac death and the role of novel myosin inhibitors in the management of HCM.

Learn more about the HCM Clinic at BIDMC: 
[ Ссылка ]

свернуть